Par Drugs and Chemicals Limited (IN:PAR)
:PAR
Want to see IN:PAR full AI Analyst Report?
Total Valuation
Par Drugs and Chemicals Limited has a market cap or net worth of ₹1.03B. The enterprise value is ₹633.62M.
Market Cap₹1.03B
Enterprise Value₹633.62M
Share Statistics
Par Drugs and Chemicals Limited has 12,304,636 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding12,304,636
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Par Drugs and Chemicals Limited’s return on equity (ROE) is 0.12 and return on invested capital (ROIC) is 8.81%.
Return on Equity (ROE)0.12
Return on Assets (ROA)0.10
Return on Invested Capital (ROIC)8.81%
Return on Capital Employed (ROCE)0.12
Revenue Per Employee8.50M
Profits Per Employee1.07M
Employee Count122
Asset Turnover0.80
Inventory Turnover9.90
Valuation Ratios
The current PE Ratio of Par Drugs and Chemicals Limited is 7.4. Par Drugs and Chemicals Limited’s PEG ratio is -3.82.
PE Ratio7.4
PS Ratio0.93
PB Ratio0.86
Price to Fair Value0.86
Price to FCF6.68
Price to Operating Cash Flow13.07
PEG Ratio-3.82
Income Statement
In the last 12 months, Par Drugs and Chemicals Limited had revenue of 1.04B and earned 131.09M in profits. Earnings per share was 10.65.
Revenue1.04B
Gross Profit504.71M
Operating Income134.28M
Pretax Income173.02M
Net Income131.09M
EBITDA171.31M
Earnings Per Share (EPS)10.65
Cash Flow
In the last 12 months, operating cash flow was 80.95M and capital expenditures -7.21M, giving a free cash flow of 73.74M billion.
Operating Cash Flow80.95M
Free Cash Flow73.74M
Free Cash Flow per Share5.99
Dividends & Yields
Par Drugs and Chemicals Limited pays an annual dividend of ₹1.25, resulting in a dividend yield of ―
Dividend Per Share₹1.25
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.94
52-Week Price Change-16.85%
50-Day Moving Average89.64
200-Day Moving Average96.89
Relative Strength Index (RSI)37.68
Average Volume (3m)31.06K
Important Dates
Par Drugs and Chemicals Limited upcoming earnings date is Jul 31, 2026, Before Open (Confirmed).
Last Earnings DateMay 14, 2026
Next Earnings DateJul 31, 2026
Ex-Dividend Date―
Financial Position
Par Drugs and Chemicals Limited as a current ratio of 4.68, with Debt / Equity ratio of 0.00%
Current Ratio4.68
Quick Ratio4.29
Debt to Market Cap0.00
Net Debt to EBITDA-2.44
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Par Drugs and Chemicals Limited has paid 41.93M in taxes.
Income Tax41.93M
Effective Tax Rate0.24
Enterprise Valuation
Par Drugs and Chemicals Limited EV to EBITDA ratio is 3.20, with an EV/FCF ratio of 3.79.
EV to Sales0.53
EV to EBITDA3.20
EV to Free Cash Flow3.79
EV to Operating Cash Flow3.34
Balance Sheet
Par Drugs and Chemicals Limited has ₹338.56M in cash and marketable securities with ₹0.00 in debt, giving a net cash position of ₹338.56M billion.
Cash & Marketable Securities₹338.56M
Total Debt₹0.00
Net Cash₹338.56M
Net Cash Per Share₹27.51
Tangible Book Value Per Share₹90.98
Margins
Gross margin is 53.15%, with operating margin of 12.95%, and net profit margin of 12.65%.
Gross Margin53.15%
Operating Margin12.95%
Pretax Margin16.69%
Net Profit Margin12.65%
EBITDA Margin16.53%
EBIT Margin12.95%
Analyst Forecast
The average price target for Par Drugs and Chemicals Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast2.66%
EPS Growth Forecast-1.90%